Treating Negative Symptoms: N-acetylcysteine for Clozapine-Resistant Schizophrenia

Research output: Contribution to journal › Comment/debate › peer-review

ASJC Scopus subject areas

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{9fe14a538e4843e581d91dd47ef5173b,

title = "Treating Negative Symptoms: N-acetylcysteine for Clozapine-Resistant Schizophrenia",

author = "Brian Miller",

year = "2022",

month = dec,

language = "English (US)",

volume = "39",

pages = "12",

journal = "Psychiatric Times",

issn = "0893-2905",

publisher = "Psychiatric Times",

number = "12",

}

TY - JOUR

T1 - Treating Negative Symptoms

T2 - N-acetylcysteine for Clozapine-Resistant Schizophrenia

AU - Miller, Brian

PY - 2022/12

Y1 - 2022/12

UR - http://www.scopus.com/inward/record.url?scp=85169338686&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85169338686&partnerID=8YFLogxK

M3 - Comment/debate

AN - SCOPUS:85169338686

SN - 0893-2905

VL - 39

SP - 12

JO - Psychiatric Times

JF - Psychiatric Times

IS - 12

ER -